Literature DB >> 11751927

Synthesis and characterization of high affinity inhibitors of the H+/peptide transporter PEPT2.

Stephan Theis1, Ilka Knutter, Bianka Hartrodt, Matthias Brandsch, Gabor Kottra, Klaus Neubert, Hannelore Daniel.   

Abstract

In this study, we describe the rational synthesis and functional analysis of novel high affinity inhibitors for the mammalian peptide transporter PEPT2. Moreover, we demonstrate which structural properties convert a transported compound into a non-translocated inhibitor. Starting from Lys[Z(NO(2))]-Pro (where Z is benzyloxycarbonyl), which we recently identified as the first competitive high affinity inhibitor of the intestinal peptide transporter PEPT1, a series of different lysine-containing dipeptide derivatives was synthesized and studied for interaction with PEPT2 based on transport competition assays in Pichia pastoris yeast cells expressing PEPT2 heterologously and in renal SKPT cells expressing PEPT2. In addition, the two-electrode voltage clamp technique in Xenopus laevis oocytes expressing PEPT2 was used to determine whether the compounds are transported electrogenically or block the uptake of dipeptides. Synthesis and functional analysis of Lys-Lys derivatives containing benzyloxycarbonyl or 4-nitrobenzyloxycarbonyl side chain protections provided a set of inhibitors that reversibly inhibited the uptake of dipeptides by PEPT2 with K(i) values as low as 10 +/- 1 nm. This is the highest affinity of a ligand of PEPT2 ever reported. Moreover, based on the structure-function relationship, we conclude that the spatial location of the side chain amino protecting group in a dipeptide containing a diaminocarbonic acid and its intramolecular distance from the Calpha atom are key factors for the transformation of a substrate into an inhibitor of PEPT2.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11751927     DOI: 10.1074/jbc.M105028200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  Bioavailability through PepT1: the role of computer modelling in intelligent drug design.

Authors:  David W Foley; Jeyaganesh Rajamanickam; Patrick D Bailey; David Meredith
Journal:  Curr Comput Aided Drug Des       Date:  2010-03       Impact factor: 1.606

2.  Future direction of renal positron emission tomography.

Authors:  Zsolt Szabo; Jinsong Xia; William B Mathews; Phillip R Brown
Journal:  Semin Nucl Med       Date:  2006-01       Impact factor: 4.446

Review 3.  The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology.

Authors:  Hannelore Daniel; Gabor Kottra
Journal:  Pflugers Arch       Date:  2003-08-07       Impact factor: 3.657

4.  Structural snapshots of human PepT1 and PepT2 reveal mechanistic insights into substrate and drug transport across epithelial membranes.

Authors:  Maxime Killer; Jiri Wald; Joanna Pieprzyk; Thomas C Marlovits; Christian Löw
Journal:  Sci Adv       Date:  2021-11-03       Impact factor: 14.136

5.  Probing the putative active site of YjdL: an unusual proton-coupled oligopeptide transporter from E. coli.

Authors:  Johanne Mørch Jensen; Fouzia Ismat; Gerda Szakonyi; Moazur Rahman; Osman Mirza
Journal:  PLoS One       Date:  2012-10-22       Impact factor: 3.240

6.  Analysing the substrate multispecificity of a proton-coupled oligopeptide transporter using a dipeptide library.

Authors:  Keisuke Ito; Aya Hikida; Shun Kawai; Vu Thi Tuyet Lan; Takayasu Motoyama; Sayuri Kitagawa; Yuko Yoshikawa; Ryuji Kato; Yasuaki Kawarasaki
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

7.  Peptide transporter isoforms are discriminated by the fluorophore-conjugated dipeptides β-Ala- and d-Ala-Lys-N-7-amino-4-methylcoumarin-3-acetic acid.

Authors:  Gabor Kottra; Britta Spanier; Tiziano Verri; Hannelore Daniel
Journal:  Physiol Rep       Date:  2013-12-08

8.  SLC15A4 Serves as a Novel Prognostic Biomarker and Target for Lung Adenocarcinoma.

Authors:  Hui Huang; Junwei Wang; Shibin Chen; HongJiang He; Yu Shang; Xiaorong Guo; Ge Lou; Jingjing Ji; Mian Guo; Hong Chen; Shan Yu
Journal:  Front Genet       Date:  2021-06-08       Impact factor: 4.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.